HIGHLIGHTS
- who: Wien Med Wochenschr ( et al. from the Univ-Klinik für, InnsbruckWienBulgaria:, University „Saint Naum", Auenbruggerplatz, Graz, Austria have published the research work: (2012) 162:354-366 in the treatment algorithm of relapsing remitting sclerosis: statement of the schubförmigen Sklerose: Eine Modulator seiner Klasse sich an Rezeptoren auf Lymphozyten bindet über Abregulation den Austritt Lymphozyten aus dem lymphatischen Gewebe in die Blutbahn verhindert, in the Journal: (JOURNAL)
- what: In this study, the administration of natalizumab had to be suspended during the open-label follow-up study when two cases of progressive multifocal leukoencephalopathy . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.